State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
Clin Infect Dis. 2012 Feb 15;54(4):527-33. doi: 10.1093/cid/cir804. Epub 2011 Dec 5.
Hemorrhagic fever-like illness caused by a novel Bunyavirus, Huaiyangshan virus (HYSV, also known as Severe Fever with Thrombocytopenia virus [SFTSV] and Fever, Thrombocytopenia and Leukopenia Syndrome [FTLS]), has recently been described in China.
Patients with laboratory-confirmed HYSV infection who were admitted to Union Hospital or Zhongnan Hospital between April 2010 and October 2010 were included in this study. Clinical and routine laboratory data were collected and blood, throat swab, urine, or feces were obtained when possible. Viral RNA was quantified by real-time reverse-transcriptase polymerase chain reaction. Blood levels of a range of cytokines, chemokines, and acute phase proteins were assayed.
A total of 49 patients with hemorrhagic fever caused by HYSV were included; 8 (16.3%) patients died. A fatal outcome was associated with high viral RNA load in blood at admission, as well as higher serum liver transaminase levels, more pronounced coagulation disturbances (activated partial thromboplastin time, thrombin time), and higher levels of acute phase proteins (phospholipase A, fibrinogen, hepcidin), cytokines (interleukin [IL]-6, IL-10, interferon-γ), and chemokines (IL-8, monocyte chemotactic protein 1, macrophage inflammatory protein 1b). The levels of these host parameters correlated with viral RNA levels. Blood viral RNA levels gradually declined over 3-4 weeks after illness onset, accompanied by resolution of symptoms and laboratory abnormalities. Viral RNA was also detectable in throat, urine, and fecal specimens of a substantial proportion of patients, including all fatal cases assayed. CONCLUSIONS. Viral replication and host immune responses play an important role in determining the severity and clinical outcome in patients with infection by HYSV.
一种新型布尼亚病毒引起的出血热样疾病,即淮河山病毒(HYSV,也称为严重发热伴血小板减少综合征病毒[SFTSV]和发热、血小板减少和白细胞减少综合征[FTLS]),最近在中国被描述。
本研究纳入了 2010 年 4 月至 2010 年 10 月期间入住协和医院或中南医院的实验室确诊为 HYSV 感染的患者。收集临床和常规实验室数据,并在可能时采集血液、咽拭子、尿液或粪便。通过实时逆转录酶聚合酶链反应定量检测病毒 RNA。检测血液中一系列细胞因子、趋化因子和急性期蛋白的水平。
共纳入 49 例由 HYSV 引起的出血热患者;8 例(16.3%)患者死亡。致命结局与入院时血液中高病毒 RNA 载量、较高的血清肝转氨酶水平、更明显的凝血障碍(活化部分凝血活酶时间、凝血酶时间)以及较高的急性期蛋白(磷脂酶 A、纤维蛋白原、铁调素)、细胞因子(白细胞介素[IL]-6、IL-10、干扰素-γ)和趋化因子(IL-8、单核细胞趋化蛋白 1、巨噬细胞炎症蛋白 1b)有关。这些宿主参数的水平与病毒 RNA 水平相关。发病后 3-4 周,血液病毒 RNA 水平逐渐下降,同时症状和实验室异常得到缓解。在相当一部分患者的咽喉、尿液和粪便标本中也可检测到病毒 RNA,包括所有进行检测的死亡病例。
结论。病毒复制和宿主免疫反应在确定 HYSV 感染患者的严重程度和临床结局方面起着重要作用。